News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
174,863 Results
Type
Article (9953)
Company Profile (35)
Press Release (164875)
Section
Business (46865)
Career Advice (302)
Deals (7668)
Drug Delivery (15)
Drug Development (22912)
Employer Resources (43)
FDA (4693)
Job Trends (3762)
News (81412)
Policy (6455)
Tag
2024 BioCapital Digital (2)
2024 BioForest Digital (2)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (3)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (3)
2025 Lone Star Bio Digital (2)
Academia (851)
Accelerated approval (2)
Adcomms (2)
Allergies (32)
Alliances (15457)
ALS (27)
Alzheimer's disease (421)
Antibody-drug conjugate (ADC) (37)
Approvals (4713)
Artificial intelligence (95)
Autoimmune disease (4)
Automation (4)
Bankruptcy (43)
Best Places to Work (3348)
BIOSECURE Act (2)
Biosimilars (14)
Biotechnology (26)
Bladder cancer (16)
Brain cancer (11)
Breast cancer (47)
Cancer (621)
Cardiovascular disease (42)
Career advice (252)
Career pathing (5)
CAR-T (41)
Cell therapy (123)
Cervical cancer (6)
Clinical research (18020)
Collaboration (285)
Compensation (36)
Complete response letters (5)
COVID-19 (1103)
CRISPR (15)
C-suite (49)
Cystic fibrosis (31)
Data (720)
Denatured (2)
Depression (10)
Diabetes (66)
Diagnostics (2696)
Digital health (5)
Diversity, equity & inclusion (10)
Drug discovery (30)
Drug pricing (5)
Drug shortages (5)
Duchenne muscular dystrophy (22)
Earnings (15226)
Editorial (5)
Employer branding (5)
Employer resources (37)
Events (22115)
Executive appointments (161)
FDA (5043)
Featured Employer (7)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (227)
Gene editing (38)
Generative AI (4)
Gene therapy (61)
GLP-1 (179)
Government (1076)
Grass and pollen (2)
Guidances (17)
Healthcare (4574)
Huntington's disease (3)
IgA nephropathy (7)
Immunology and inflammation (29)
Indications (6)
Infectious disease (1161)
Inflammatory bowel disease (45)
Inflation Reduction Act (1)
Influenza (20)
Intellectual property (27)
Interviews (32)
IPO (3232)
IRA (3)
Job creations (537)
Job search strategy (228)
Kidney cancer (2)
Labor market (1)
Layoffs (57)
Leadership (4)
Legal (710)
Liver cancer (19)
Lung cancer (66)
Lymphoma (34)
Management (13)
Manufacturing (83)
MASH (9)
Medical device (3652)
Medtech (3653)
Mergers & acquisitions (4566)
Metabolic disorders (160)
Multiple sclerosis (35)
NASH (3)
Neurodegenerative disease (26)
Neuropsychiatric disorders (5)
Neuroscience (542)
NextGen: Class of 2025 (1545)
Non-profit (858)
Northern California (712)
Now hiring (6)
Obesity (88)
Opinion (42)
Ovarian cancer (14)
Pain (26)
Pancreatic cancer (23)
Parkinson's disease (25)
Partnered (5)
Patents (53)
Patient recruitment (39)
Peanut (16)
People (13352)
Pharmaceutical (8)
Phase I (6456)
Phase II (8101)
Phase III (5579)
Pipeline (365)
Podcasts (4)
Policy (11)
Postmarket research (426)
Preclinical (2867)
Press Release (31)
Prostate cancer (23)
Psychedelics (5)
Radiopharmaceuticals (63)
Rare diseases (102)
Real estate (1496)
Recruiting (21)
Regulatory (5216)
Reports (13)
Research institute (836)
Resumes & cover letters (46)
Rett syndrome (1)
RNA editing (2)
RSV (8)
Schizophrenia (6)
Series A (47)
Series B (31)
Service/supplier (3)
Sickle cell disease (17)
Southern California (531)
Special edition (1)
Spinal muscular atrophy (35)
Sponsored (5)
Startups (1078)
Stomach cancer (2)
Supply chain (15)
Tariffs (1)
The Weekly (1)
United States (5701)
Vaccines (199)
Venture capitalists (6)
Webinars (2)
Weight loss (44)
Women's health (6)
Worklife (2)
Date
Today (23)
Last 7 days (168)
Last 30 days (738)
Last 365 days (9490)
2025 (2350)
2024 (9803)
2023 (11483)
2022 (17549)
2021 (18454)
2020 (17470)
2019 (11981)
2018 (9087)
2017 (8676)
2016 (8115)
2015 (9318)
2014 (6475)
2013 (5153)
2012 (5593)
2011 (5999)
2010 (5028)
Location
Africa (174)
Alabama (10)
Arizona (38)
Arkansas (6)
Asia (10352)
Australia (1856)
California (1534)
Canada (504)
China (130)
Colorado (68)
Connecticut (84)
Delaware (19)
Europe (24798)
Florida (267)
Georgia (67)
Idaho (15)
Illinois (99)
India (6)
Indiana (48)
Iowa (4)
Japan (42)
Kansas (40)
Kentucky (2)
Maine (7)
Maryland (210)
Massachusetts (1225)
Michigan (64)
Minnesota (42)
Missouri (19)
Montana (11)
Nebraska (3)
Nevada (11)
New Hampshire (13)
New Jersey (401)
New Mexico (8)
New York (443)
North Carolina (257)
North Dakota (2)
Northern California (712)
Ohio (46)
Oklahoma (7)
Oregon (8)
Pennsylvania (276)
Puerto Rico (4)
Rhode Island (11)
South America (208)
South Carolina (2)
South Dakota (1)
Southern California (531)
Tennessee (21)
Texas (230)
Utah (32)
Virginia (44)
Washington D.C. (9)
Washington State (142)
West Virginia (1)
Wisconsin (17)
174,863 Results for "rapid micro biosystems".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rapid Micro Biosystems to Participate in Upcoming March 2025 Investor Conferences
February 27, 2025
·
1 min read
Press Releases
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Guidance
March 3, 2025
·
11 min read
Press Releases
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025
February 21, 2025
·
1 min read
Press Releases
Rapid Micro Biosystems Announces Global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany
February 28, 2025
·
6 min read
Press Releases
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenue
January 14, 2025
·
7 min read
Press Releases
Rapid Micro Biosystems to Present at 43ʳᵈ Annual J.P. Morgan Healthcare Conference
January 7, 2025
·
1 min read
Press Releases
Rapid Micro Biosystems to Participate in the Stifel 2024 Healthcare Conference
November 8, 2024
·
1 min read
Business
Rapid Micro Biosystems Reports First Quarter 2024 Financial Results
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the first quarter ended March 31, 2024.
May 3, 2024
·
9 min read
Press Releases
Rapid Micro Biosystems Reports Third Quarter 2024 Financial Results
November 4, 2024
·
9 min read
Genetown
Rapid Micro Biosystems to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”) today announced that the Company will participate in the virtual KeyBanc Life Sciences & MedTech Investor Forum on March 19, 2024.
March 12, 2024
·
1 min read
1 of 17,487
Next
